Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BMC for Knee Osteoarthritis
NCT03110666Phase 4Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Nov 2016
- Primary completion
- Nov 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of autologous bone marrow cell concentrate in knee osteoarthritis (OA), sponsored by Istituto Ortopedico Rizzoli. Started Nov 2016; status: completed.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03110666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110666.